ICCC ImmuCell Corporation
Price Chart
Executive Summary
ImmuCell reported preliminary Q1 2026 sales of $10.4M, up 28.4% YoY, driven by a 38.5% surge in Tri-Shield® sales. International sales declined 30.2%, and EPS was a loss of $0.31. The company cited ongoing operational challenges from prior backlogs but expressed confidence in its growth strategy.
Actionable Insight
Traders should monitor the upcoming full financial release and conference call for clarity on gross margins, operating leverage, and whether domestic strength can offset international weakness; sustained Tri-Shield® momentum may support bullish sentiment if profitability improves.
Key Facts
- Q1 2026 total sales: $10.4 million, up 28.4% YoY from $8.1 million
- Domestic sales grew 35.7% to $9.7 million
- International sales fell 30.2% to $0.6 million
- Tri-Shield® sales increased 38.5% to $7.9 million
- Dual Force® & Other sales up 4.4% to $2.5 million
- EPS reported as -$0.31, though no consensus estimate was available
- Company hosted a conference call on May 15, 2026, to discuss unaudited results
Financial Impact
Revenue increased by $2.3 million YoY, but international segment declined sharply; net income not disclosed but EPS loss of $0.31 indicates continued unprofitability
Risk Factors
- International sales declined significantly (-30.2%), raising concerns about global demand or distribution
- Ongoing backorder recovery may distort future growth comparisons
- EPS remains negative, indicating continued losses despite revenue growth
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3270500 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 8, 2026
4w ago
|
8-K
| $8.45 $9.91 | ▲ +17.28% | ▲ +17.36% | $9.70 (+14.79%) |
|
Apr 8, 2026
8w ago
|
8-K
| $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $9.70 (+34.91%) |
|
Apr 8, 2026
8w ago
|
Press Release
| $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $9.70 (+34.91%) |
|
Mar 4, 2026
13w ago
|
8-K
| $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $9.70 (+52.76%) |
|
Mar 4, 2026
13w ago
|
Press Release
| $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $9.70 (+52.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access